Successful treatment with weekly high-dose erlotinib against meningeal metastases from epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma.
Respir Investig
; 54(5): 372-5, 2016 Sep.
Article
in En
| MEDLINE
| ID: mdl-27566387
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Adenocarcinoma
/
ErbB Receptors
/
Erlotinib Hydrochloride
/
Lung Neoplasms
/
Meningeal Neoplasms
/
Mutation
Limits:
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Respir Investig
Year:
2016
Document type:
Article